CS MEDICA A/S Announces Strategic Partnership with Scan MedPartners to Expand Reach into the US Market
CS MEDICA A/S targets the US market for its regulated treatments with bioactive cannabidiol (CBD), complementing prescription-based therapies and non-regulated CBD products.CS MEDICA A/S, a Danish MedTech company specializing in pain management, autoimmune diseases, and stress-related disorders, is pleased to announce a new strategic partnership with Scan MedPartners, a US consultancy with a deep network and expertise in connecting Scandinavian medical technology companies with qualified high-value US partners in search of clinically proven, disruptive platform technologies, to improve